1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Stonepine Capital Management, LLC Buys Viveve Medical Inc, Avadel Pharmaceuticals PLC, Ophthotech Corp, Sells Sucampo Pharmaceuticals Inc, Alere Inc, Veracyte Inc

Investment company Stonepine Capital Management, LLC buys Viveve Medical Inc, Avadel Pharmaceuticals PLC, Ophthotech Corp, SciClone Pharmaceuticals Inc, Vericel Corp, Emergent BioSolutions Inc, Durect Corp, XOMA Corp, Vanda Pharmaceuticals Inc, sells Sucampo Pharmaceuticals Inc, Alere Inc, Veracyte Inc, Alimera Sciences Inc, Mallinckrodt PLC during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Stonepine Capital Management, LLC. As of 2017-03-31, Stonepine Capital Management, LLC owns 20 stocks with a total value of $164 million. These are the details of the buys and sells.

For the details of Stonepine Capital Management, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Stonepine+Capital+Management%2C+LLC

These are the top 5 holdings of Stonepine Capital Management, LLC
  1. Recro Pharma Inc (REPH) - 2,874,317 shares, 15.3% of the total portfolio.
  2. Viveve Medical Inc (VIVE) - 3,849,711 shares, 14.77% of the total portfolio. Shares added by 48.08%
  3. Novelion Therapeutics Inc (NVLN) - 1,560,487 shares, 10.21% of the total portfolio. Shares added by 2.39%
  4. SciClone Pharmaceuticals Inc (SCLN) - 1,663,281 shares, 9.93% of the total portfolio. Shares added by 33.15%
  5. Ophthotech Corp (OPHT) - 3,516,489 shares, 7.84% of the total portfolio. Shares added by 53.36%
New Purchase: Avadel Pharmaceuticals PLC (AVDL)

Stonepine Capital Management, LLC initiated holdings in Avadel Pharmaceuticals PLC. The purchase prices were between $9.15 and $11.57, with an estimated average price of $10. The stock is now traded at around $10.14. The impact to the portfolio due to this purchase was 4.44%. The holdings were 752,410 shares as of 2017-03-31.

New Purchase: Emergent BioSolutions Inc (EBS)

Stonepine Capital Management, LLC initiated holdings in Emergent BioSolutions Inc. The purchase prices were between $28.36 and $34.66, with an estimated average price of $30.44. The stock is now traded at around $31.53. The impact to the portfolio due to this purchase was 0.96%. The holdings were 54,505 shares as of 2017-03-31.

New Purchase: XOMA Corp (XOMA)

Stonepine Capital Management, LLC initiated holdings in XOMA Corp. The purchase prices were between $4.03 and $7.14, with an estimated average price of $5.14. The stock is now traded at around $6.48. The impact to the portfolio due to this purchase was 0.38%. The holdings were 87,960 shares as of 2017-03-31.

New Purchase: Vanda Pharmaceuticals Inc (VNDA)

Stonepine Capital Management, LLC initiated holdings in Vanda Pharmaceuticals Inc. The purchase prices were between $13.05 and $15.95, with an estimated average price of $14.25. The stock is now traded at around $14.45. The impact to the portfolio due to this purchase was 0.37%. The holdings were 43,300 shares as of 2017-03-31.

Added: Viveve Medical Inc (VIVE)

Stonepine Capital Management, LLC added to the holdings in Viveve Medical Inc by 48.08%. The purchase prices were between $3.99 and $6.33, with an estimated average price of $4.86. The stock is now traded at around $7.81. The impact to the portfolio due to this purchase was 4.8%. The holdings were 3,849,711 shares as of 2017-03-31.

Added: Ophthotech Corp (OPHT)

Stonepine Capital Management, LLC added to the holdings in Ophthotech Corp by 53.36%. The purchase prices were between $3.28 and $5.13, with an estimated average price of $4.23. The stock is now traded at around $2.58. The impact to the portfolio due to this purchase was 2.73%. The holdings were 3,516,489 shares as of 2017-03-31.

Added: SciClone Pharmaceuticals Inc (SCLN)

Stonepine Capital Management, LLC added to the holdings in SciClone Pharmaceuticals Inc by 33.15%. The purchase prices were between $9.4 and $10.85, with an estimated average price of $9.99. The stock is now traded at around $9.75. The impact to the portfolio due to this purchase was 2.47%. The holdings were 1,663,281 shares as of 2017-03-31.

Added: Vericel Corp (VCEL)

Stonepine Capital Management, LLC added to the holdings in Vericel Corp by 73.34%. The purchase prices were between $2.5 and $3.1, with an estimated average price of $2.83. The stock is now traded at around $2.65. The impact to the portfolio due to this purchase was 2.36%. The holdings were 3,265,323 shares as of 2017-03-31.

Added: Durect Corp (DRRX)

Stonepine Capital Management, LLC added to the holdings in Durect Corp by 28.63%. The purchase prices were between $0.91 and $1.37, with an estimated average price of $1.07. The stock is now traded at around $1.28. The impact to the portfolio due to this purchase was 0.4%. The holdings were 2,801,376 shares as of 2017-03-31.

Sold Out: Sucampo Pharmaceuticals Inc (SCMP)

Stonepine Capital Management, LLC sold out the holdings in Sucampo Pharmaceuticals Inc. The sale prices were between $10.25 and $13.95, with an estimated average price of $11.61.

Sold Out: Mallinckrodt PLC (MNK)

Stonepine Capital Management, LLC sold out the holdings in Mallinckrodt PLC. The sale prices were between $42.54 and $54.74, with an estimated average price of $49.35.

Sold Out: Cutera Inc (CUTR)

Stonepine Capital Management, LLC sold out the holdings in Cutera Inc. The sale prices were between $17.45 and $21.9, with an estimated average price of $19.73.

Sold Out: Juniper Pharmaceuticals Inc (JNP)

Stonepine Capital Management, LLC sold out the holdings in Juniper Pharmaceuticals Inc. The sale prices were between $4.6 and $5.75, with an estimated average price of $5.05.



Here is the complete portfolio of Stonepine Capital Management, LLC. Also check out:

1. Stonepine Capital Management, LLC's Undervalued Stocks
2. Stonepine Capital Management, LLC's Top Growth Companies, and
3. Stonepine Capital Management, LLC's High Yield stocks
4. Stocks that Stonepine Capital Management, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


HOLKLSULucky Eight Value Over Growth
HOLKLSU=Lucky Eight Value Over Growth
pbarker46RSI & 3 year low
rael2222X
rael2222R
nalchionShort2
nalchionShort1
baz27sales day -baz1
Sachin133Undervalued%20Stocks-1
Angryscreen
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK